Impact of the Time Interval Between MDCT Imaging and Surgery on the Accuracy of Identifying Metastatic Disease in Patients With Pancreatic Cancer
- 1 January 2015
- journal article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 204 (1) , W37-W42
Abstract
OBJECTIVE. Pancreatic adenocarcinoma is a rapidly progressive malignancy characterized by its tendency for early metastatic spread. MDCT is the primary diagnostic modality for the preoperative staging of patients with pancreatic cancer, with an accuracy established in multiple studies. However, for a variety of reasons, there is often a prolonged interval between staging MDCT and the surgical intervention. This study examines the relationship between the interval between imaging and surgery and the accuracy of MDCT in determining the presence or absence of metastatic disease at surgery in patients with pancreatic cancer. MATERIALS AND METHODS. Patients were identified who had undergone surgery for pancreatic cancer at our institution with a dedicated preoperative pancreas-protocol MDCT performed in our department. Findings from the preoperative MDCT report were correlated with the operative findings, as well as the time between imaging and surgery. RESULTS. Two hundred ninety-two MDCT scans were performed...Keywords
This publication has 22 references indexed in Scilit:
- Imaging of pancreatic ductal adenocarcinoma: State of the artWorld Journal of Radiology, 2013
- Multimodality Imaging of Pancreatic Cancer—Computed Tomography, Magnetic Resonance Imaging, and Positron Emission TomographyThe Cancer Journal, 2012
- Imaging of Pancreatic Adenocarcinoma: Update on Staging/ResectabilityRadiologic Clinics of North America, 2012
- Accuracy of Multislice Liver CT and MRI for Preoperative Assessment of Colorectal Liver Metastases after Neoadjuvant ChemotherapyDigestive Surgery, 2011
- Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus StatementAnnals of Surgical Oncology, 2009
- Surgical Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus StatementAnnals of Surgical Oncology, 2009
- Value of three-dimensional reconstructions in pancreaticcarcinoma using multidetector CT: Initial resultsWorld Journal of Gastroenterology, 2009
- Pancreatic Duodenal Homeobox 1 Expression Is Insufficient to Transdifferentiate Liver Cells Into Insulin-Secreting CellsPancreas, 2007
- Predicting resectability of periampullary cancer with three-dimensional computed tomographyJournal of Gastrointestinal Surgery, 2004
- Locally Weighted Regression: An Approach to Regression Analysis by Local FittingJournal of the American Statistical Association, 1988